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ABSTRACT Achondroplasia, the most common form of human dwarﬁsm, is due to a G380R mutation in the transmembrane
domain of ﬁbroblast growth factor receptor 3 (FGFR3) in .97% of the studied cases. While the molecular mechanism of pa-
thology induction is under debate, the structural consequences of the mutation have not been studied. Here we use neutron dif-
fraction to determine the disposition of FGFR3 transmembrane domain in ﬂuid lipid bilayers, and investigate whether the G380R
mutation affects the topology of the protein in the bilayer. Our results demonstrate that, in a model system, the G380R mutation
induces a shift in the segment that is embedded in the membrane. The center of the hydrocarbon core-embedded segment in the
mutant is close to the midpoint between R380 and R397, supporting previous measurements of arginine insertion energetics into
the endoplasmic reticulum. The presented results further our knowledge about basic amino-acid insertion into bilayers, and may
lead to new insights into the mechanism of pathogenesis in achondroplasia.
INTRODUCTION
Hydropathy plot analysis is widely used to identify mem-
brane-embedded segments in membrane proteins and predict
membrane protein topologies (1,2). Usually, a prediction is
considered correct if there is an overlap between the known
and the predicted transmembrane (TM) helices, irrespective
of the exact helix length (3). Predictions of exact hydrocar-
bon core-embedded sequences, however, are rarely correct.
Furthermore, recent work by Hessa et al. (4,5) has demon-
strated that for some amino acids, particularly hydrophilic
charged ones, the free energy of partitioning into the mem-
brane depends strongly on the position of the amino acid
within the bilayer thickness. The observed positional depen-
dence is not yet incorporated into hydropathy prediction
tools, and thus the identiﬁcation of exact hydrocarbon core-
embedded segments is a challenge. The need therefore re-
mains to experimentally determine transmembrane segments,
by measuring the depth of penetration of speciﬁc amino
acids within the bilayer thickness.
Two methods, ﬂuorescence quenching (6–8) and elec-
tron paramagnetic resonance (EPR) spectroscopy (9–12), are
often used to obtain the depth of penetration of a speciﬁc
amino-acid residue of a protein into the bilayer. A ‘‘reporter
molecule,’’ such as a ﬂuorophore or an EPR probe, is at-
tached to a speciﬁc cysteine in the protein, and the exper-
iments ‘‘locate the reporter’’ within the bilayer thickness.
The precision in determining the depth of penetration using
these two methods is 1.5–3 A˚.
Neutron diffraction experiments, combined with speciﬁc
deuteration of amino acids of interest (13–16), can offer
some advantages over the methods of EPR and ﬂuorescence
quenching. First, diffraction gives direct structural informa-
tion (as opposed to, say, ﬂuorescence, where we measure the
ﬂuorescence signal, and infer structure from the signal).
Second, the experimental resolution of diffraction experi-
ments can be very high, ;0.2 A˚ (17). Third, in a diffraction
experiment we can obtain and compare structural character-
istics with and without the label and thus determine if the
protein disposition and the overall structure of the bilayer
changes in the presence of the label. This is not an option for
either EPR or ﬂuorescence, where the signal is present only
in the presence of the label.
In neutron diffraction experiments, contrast is introduced
by selective deuteration of amino acids. Although hydrogen-
deuterium substitutions in membrane proteins are expected
to not perturb the structure of the proteins in the bilayer and
the structure of the bilayer itself, the lack of such perturba-
tions has not been demonstrated explicitly. Furthermore, it
is not known if the selective deuteration of an amino acid
provides sufﬁcient contrast, such that the depth of penetra-
tion of the label can be determined reliably using neutron
diffraction.
Here we explore the feasibility of determining depth of
penetration of amino acids in transmembrane domains using
neutron diffraction. We use the methodology to obtain struc-
tural information about the naturally occurring transmem-
brane domain sequence of human ﬁbroblast growth factor
receptor 3 (FGFR3). FGFR3 is a receptor tyrosine kinase that
conducts biochemical signals via lateral dimerization in the
membrane plane. It consists of an extracellular ligand bind-
ing domain, a single TM domain, and a cytoplasmic catalytic
domain, and the TM domain has been shown to play an im-
portant role in the signal transduction process (18,19).
In our laboratory, we study the biophysics behind defects
in FGFR3 signaling due to pathogenic mutations in the TM
Submitted June 26, 2006, and accepted for publication August 17, 2006.
Address reprint requests to K. Hristova, Tel.: 410-516-8939; E-mail: kh@
jhu.edu.
 2006 by the Biophysical Society
0006-3495/06/11/3736/12 $2.00 doi: 10.1529/biophysj.106.092247
3736 Biophysical Journal Volume 91 November 2006 3736–3747
domain (20–22). These mutations have been identiﬁed in
genetic studies of patients afﬂicted by growth disorders and
cancers (23,24), but the effect of these mutations on protein-
protein and protein-lipid interactions are not well under-
stood.
An example of a pathogenic FGFR3 TM mutation is the
G380R mutation linked to achondroplasia, the most com-
mon form of human dwarﬁsm, in .97% of all studied cases
(24,25). While receptor tyrosine kinase TM domain muta-
tions are generally believed to induce pathologies by sta-
bilizing the active dimeric state of the receptors (26,27), the
molecular mechanism behind achondroplasia is under de-
bate and different mechanisms may contribute to the in-
duction of the phenotype (22,28–30). From a structural
perspective, it is intriguing that the mutation introduces an
arginine in the middle of the predicted TM domain of the
protein. Arginine is rarely found in the bilayer hydrocarbon
core, and it is possible that the G380R substitution induces a
shift in the membrane-embedded segment of the protein;
such a shift may be the structural basis of pathogenesis in
achondroplasia.
The hydropathy plot prediction of the membrane-embed-
ded FGFR3 segment, carried out using Membrane Protein
Explorer (http://blanco.biomol.uci.edu/mpex/), suggests that
the TM domains of wild-type and mutant are the same, with
R380 inserted in the bilayer (22) (see Fig. 1). R380 is
surrounded by very hydrophobic amino acids, and such pre-
diction is not surprising. Hessa et al. (4), however, have dem-
onstrated a strong dependence of the penalty for inserting
arginine on its depth of penetration into the hydrocarbon
core; this penalty is the highest in the middle of the bi-
layer. Thus, it is unlikely that the location of R380 within
the bilayer, and the topology of the mutant TM domain,
can be predicted accurately with current hydropathy plot
algorithms that do not take into account the observed posi-
tional dependence.
The neutron diffraction structural methods, used here to
study the topology of the wild-type FGFR3 TM domain and
the achondroplasia-causing mutant, are based on the analysis
of the so-called ‘‘absolute, or per-lipid’’ structure factors
(31–33). These absolute structure factors are determined by
the scattering of the unit cell, and do not depend on the exact
experimental conditions such as amount of sample in the
beam, precise geometry, etc. The absolute scale methodol-
ogy has previously provided valuable information about the
structure of ﬂuid bilayers, such as the complete structure of
the DOPC bilayer (34) and the position of amphipathic
helices within the bilayer interface (35,36). Now we extend
this methodology to determine the depth of penetration of
amino acids in the ﬂuid bilayer, as well as the topology of the
FGFR3 TM domain in the bilayer.
Here we show that the depth of penetration of amino acids
into the hydrocarbon core can indeed be determined using
neutron diffraction. The results from the diffraction exper-
iments, together with oriented circular dichroism (OCD)
measurements of FGFR3 helix tilt in bilayers, can be used to
identify the membrane-embedded segment of the R380
FGFR3 mutant. We ﬁnd that R380 in the mutant is located at
;11 A˚ from the bilayer center, within the hydrocarbon core
of the bilayer. We further ﬁnd that the G380R mutation
induces a shift in the hydrocarbon core- embedded segment
of the protein. The presented structural work furthers our
knowledge about basic amino-acid insertion into bilayers,
and addresses, for the ﬁrst time, the structural consequences
of the achondroplasia mutation.
MATERIALS AND METHODS
Sample preparation
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was purchased
from Avanti Polar Lipids (Alabaster, AL), D2O from Cambridge Isotope
Labs (Andover, MA), amino acids from Advanced Chemtech (Louisville,
KY), and deuterated amino acids (Phe, Leu, Val) from CDN isotope (Pointe-
Claire, Quebec). Peptide synthesis details were reported previously (37).
Multilayer samples containing 4 mol % TMwt, TM
DðFLÞ
wt , TMmut, TM
DðFLÞ
mut ,
and TM
DðLVVÞ
mut (see Fig. 1 for sequences) were prepared by dissolving the
peptides in a mixture of triﬂuoroethanol and hexaﬂuoroisopropanol (2:1
ratio) and the lipid (POPC) in chloroform (38,39). The two solutions were
mixed in the appropriate ratios and deposited on a thin glass slide, which was
followed by the gradual and complete evaporation of the solvents. The
multilayer sample size was ;15 mm 3 17 mm 3 0.5 mm.
Oriented CD
The above method was also used to prepare samples for oriented circular
dichroism (OCD) measurements, such that neutron and OCD results can be
directly compared. A multilayer sample was deposited on a quartz slide. The
FIGURE 1 Amino-acid sequences of the ﬁve human
FGFR3 TM domain variants studied here, with the
predicted hydrocarbon core-embedded segments under-
lined. Hydropathy plot predictions were carried out using
Membrane Protein Explorer, a Java applet available over
the WWW (http://blanco.biomol.uci.edu/mpex/). The deu-
terated amino acids are shown in bold. The G380R
mutation (italic) has been linked to achondroplasia, the
most common form of dwarﬁsm in humans.
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slide was placed in a custom-designed chamber with the multilayers
perpendicular to the beam (35,36,40–42). To hydrate at 76% relative
humidity (RH), a drop of saturated NaCl solution was placed in the chamber
and the sample was equilibrated for several hours (32,36). The sample was
rotated around the beam axis in increments of 45, such that eight spectra
were recorded for each sample. The spectra shown in Fig. 2 were obtained
after averaging and lipid background corrections.
Neutron diffraction experiments, data collection
and analysis
Neutron diffraction experiments were performed at the Advanced Neutron
Diffractometer/Reﬂectometer at the National Institute of Standards and
Technology Center for Neutron Research (Gaithersburg, MD). Relative
humidity of 76% was achieved using a saturated NaCl solution, as pre-
viously described (32). Each multilayer sample was hydrated using H2O
mixed with 0%, 20%, and 50% D2O. The solution was placed next to the
sample in a sealed aluminum container, and diffraction pattern changes were
followed during sample equilibration. Typically, 6;7 h were needed for
complete equilibration.
The wavelength of the neutron beam was 5 A˚. The intensity of the
diffracted beam was recorded during Q–2Q scans using an He-3 gas-ﬁlled
25.4-mm-wide pencil detector (GE Reuter-Stokes, Twinsburg, OH). Data
processing was performed using Reﬂred, a software written for the Ad-
vanced Neutron Diffractometer/Reﬂectometer, and the commercially avail-
able package Origin (OriginLab, Northampton, MA).
The observed structure factors were calculated as
f ðhÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
IðhÞAðhÞsinð2QÞ
p
; (1)
where I(h) is the intensity of the hth peak, A(h) is the absorption correction,
and sin(2Q) is the Lorentz factor. The absorption correction is given by (43)
AðhÞ ¼ sinQ
2mt
½1 exp2mt=sinQ; (2)
where Q is the Bragg angle, t is the sample thickness, and m is the linear
absorption coefﬁcient of the sample. In all cases, A(h) did not exceed 1.005,
such that the absorption correction was negligible.
Absolute scaling
The absolute scattering length density r*(z) is the scattering density per one
lipid molecule, given by (33)
r
ðzÞ ¼ rðzÞS ¼ r01
2
d
1
k
+
hobs
h¼1
f ðhÞcos 2phz
d
 
; (3)
where f(h) are the measured structure factors on an arbitrary scale, k is the
instrumental constant, d is the Bragg spacing, r0 is the average scattering
length density of the unit cell, and hobs is the highest observed diffraction
order. F(h) ¼ f(h)/ k are the absolute structure factors, which are determined
solely by the structure and the scattering of the unit cell (17,32).
The instrumental constant k and the absolute structure factors F(h) ¼
f(h)/ k can be determined if diffraction patterns are recorded for two samples,
with unit cells which are identical except for a few atoms that have
large differences in scattering lengths (i.e., isomorphous unit cells). Here
the absolute scale proﬁles were determined by comparing structure factors
for POPC bilayers containing 4 mol % TMwt and TM
DðFLÞ
wt , 4 mol % TMmut
and TM
DðFLÞ
mut , and 4 mol % TMmut and TM
DðLVVÞ
mut , as discussed below.
The D(FL) and D(LVV) deuterium labels introduce only 0.625 and 1.08
deuterons per lipid, respectively (see Results, below). Large random errors
in the experimental structure factors can ‘‘obscure’’ the contrast provided by
the deuterium label. The random errors in the experimental structure factors
were therefore minimized by placing the structure factors for each peptide on
a self-consistent arbitrary scale and linearizing them with D2O concentra-
tion, as described previously (17,32). The four sets of structure factors
ff0(h), f20(h), and f50(h)g, recorded for 100% H2O, 20% H2O 1 80% D2O,
and 50% H2O 1 50% D2O hydration, are linear with D2O concentration,
thus demonstrating that the D2O/H2O replacement is isomorphous (see Fig.
3). Therefore, the following relation holds for structure factors of a particular
multilayer sample collected at 0, 20, and 50% D2O (17),
f20ðhÞ
k20
¼ 0:6 f0ðhÞ
k0
1 0:4
f50ðhÞ
k50
; (4)
where k0, k20, and k50 are self-consistent, yet arbitrary instrumental constants
for 100% H2O, 20% H2O 1 80% D2O, and 50% H2O 1 50% D2O, re-
spectively. The linear relationship (4) can be used to ﬁnd the self-consistent
arbitrary instrumental constants and the ‘‘best’’ statistical estimates of the
observed structure factors f f 0ðhÞ, f 20ðhÞ, and f 50ðhÞg from parameters of the
best-ﬁt straight lines passing through the experimental structure factors (see
further details in (17,32)).
Next, the best estimates of the experimental structure factors f
wt
0 ðhÞ,
f
wt D
0 ðhÞ, f
mut
0 ðhÞ, and f
mut D
0 ðhÞ, recorded for 100% H2O, were used to
obtain the instrumental constants needed to place these structure factors on
the absolute scale, using
FIGURE 2 Oriented CD spectra of 4 mol % TMwt, TM
DðFLÞ
wt , TMmut,
TM
DðFLÞ
mut , and TM
DðLVVÞ
mut in POPC multilayers equilibrated at 76% RH.
Peptides and lipids (molar ratio 1:24) were mixed in HFIP/TFE/chloroform,
deposited on a quartz slide, and hydrated to form multilayers. The experi-
mental spectra are compared to theoretical spectra of helices (inset) with tilts
of 0 (solid line), 10 (dashed line), 20 (dotted line), 30 (dashed dotted
line), and 90 (dashed dotted-dotted line) with respect to the bilayer normal.
The theory predicts that tilts of 20 and higher will result in the appearance
of a minimum at;205 nm (inset). The OCD signal of a TM helix is very low
and challenging to measure above the lipid background, particularly at lower
wavelengths, and the amplitude of the signal depends on the thickness of the
sample, which is hard to control. Thus, the observed difference in amplitude
in the experimental spectra is not statistically signiﬁcant (22,37). Based on
the shape of the experimental data, showing no deﬁned peak at 205 nm, it
appears that all peptides are transmembrane and their tilt with respect to the
bilayer normal is 20 or less.
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f
wt D
0 ðhÞ
k
wt D
0
 f
wt
0 ðhÞ
k
wt
0
¼ 2bDexp  pAwtD h=d
 2 
cosð2phZwtD =dÞ; h ¼ 1 . . . : :hobs; (5)
f
mut D
0 ðhÞ
k
mut D
0
 f
mut
0 ðhÞ
k
mut
0
¼ 2bDexp  pAmutD h=d
 2 
cosð2phZmutD =dÞ; h ¼ 1 . . . : :hobs: (6)
Here AD and ZD are the width and the position of the peptide deuterium label,
either D(FL) or D(LVV), that we would like to determine for the wild-type
and the mutant, fk0g are the instrumental constants, and bD is the neutron
scattering length difference due to the hydrogen/deuterium substitution in
the peptide. Five orders of diffraction were recorded in all experiments, such
that hobs ¼ 5. Therefore, the overdetermined system of ﬁve expressions
(Eq. 5) can be used to ﬁnd the four unknown parameters for wild-type:
k
wt
0 ; k
wt D
0 ; A
wt
D ; Z
wt
D . The other ﬁve sets of expressions (Eq. 6) are used to
calculate the four unknown parameters for mutant: k
mut
0 ; k
mut D
0 ; A
mut
D ; Z
mut
D .
Knowing the instrumental constants k0, we can now determine the
absolute structure factors for 100% H2O, F
wt
0 ðhÞ ¼ ðf wt0 hð Þ=k
wt
0 Þ, Fwt D0 ðhÞ ¼
ðf wt D0 hð Þ=k
wt
0 Þ, Fmut0 ðhÞ ¼ ðfmut0 hð Þ=k
mut
0 Þ, and Fmut D0 ðhÞ ¼ ðfmut D0 hð Þ=k
mut
0 Þ,
as well as their best estimates F
wt
0 ðhÞ ¼ ðf
wt
0 hð Þ=k
wt
0 Þ, Fwt D0 ðhÞ ¼
ðf wt D0 ðhÞ=k
wt D
0 Þ, Fmut0 ðhÞ ¼ ðf
mut
0 hð Þ=k
mut
0 Þ, and Fmut D0 ðhÞ ¼ ðf
mut D
0 ðhÞ=
k
mut D
0 Þ. Next, we ﬁnd the instrumental constants for the structure factors
collected at 20% and 50% D2O, according to
f jðhÞ
kj
 F0 ¼ 2bwNwjexp  pAwh=d½ 2
	 

cosð2phZw=dÞ; h ¼ 1 . . . : :hobs; (7)
where j is the D2O fraction (either 20% or 50%), Nw is the number of water
molecules per lipid, and bw is the neutron scattering length difference
between H2O and D2O. The four unknowns, to be calculated from the over-
determined system of ﬁve expressions (Eq. 7), are the parameters of the
water distribution Aw, Zw, and Nw, and the instrumental constant. Finding the
set of instrumental constants kj allows us to determine the absolute structure
factors FjðhÞ ¼ fjðhÞ=kj and their best estimates FjðhÞ ¼ fjðhÞ=kj for j ¼
20% or 50%.
Error analysis
The experimental errors in the structure factorss(h) were determined from the
square roots of the integrated peak areas and the background below the peaks,
as described previously (32;35). The quality of the neutron data was described
by the so-called self R-factor, Rself ¼ +hobsh¼1 sðhÞ=+
hobs
h¼1 FðhÞ (35). The value
of Rself was compared to Rdiff ¼ +hobsh¼1 DFðhÞ=+
hobs
h¼1 FðhÞ, where DF(h) are
the difference structure factors due to the deuterium label. The position of
the label can be determined and the structure factors can be scaled only if the
changes in the structure factors due to the label are larger than the random
noise in the structure factors, i.e., if Rdiff. Rself . The values of Rdiff are given
in Table 2, and Rself values are given in Table 1. In all cases, Rdiff . Rself.
R-factors of ﬁts were calculated according to Rfit ¼ +hobsh¼1 jðF FfitÞðhÞj=
+hobs
h¼1 jFðhÞj, where Fﬁt are the calculated structure factors for the optimal
position and width of the deuterium label. A ﬁt was considered good if Rﬁt,
Rself. Values for Rﬁt are shown in Tables 2 and 3 for the peptide label and the
water distributions, respectively. In all cases, Rﬁt , Rself, indicative of good
ﬁts.
RESULTS
Direct determination of depth of penetration of
amino acids in a ﬂuid bilayer
Peptides corresponding to the wild-type and mutant FGFR3
TM domains (TMwt and TMmut, and deuterated variants, see
Fig. 1) were produced by solid phase peptide synthesis (37).
Solid-phase peptide synthesis is uniquely suited for intro-
ducing deuterated amino acids of choice into any sequence.
A question arises, however, about the deuterium detection
limit in neutron diffraction experiments (i.e., the number of
deuterons per lipid that can be detected), as determined by
the number of deuterons per peptide and the peptide/lipid
ratio. Preliminary experiments, monitoring changes in struc-
ture factors as a function of D2O content in the hydrating
atmosphere (unpublished results), were used to estimate the
FIGURE 3 Observed structure factors for
POPC multilayers containing 4 mol % TMwt,
TM
DðFLÞ
wt , TMmut, and TM
DðFLÞ
mut , equilibrated at
76% RH, as a function of D2O mol %. The
structure factors have been placed on the abso-
lute (per lipid) scale, as described in Materials
and Methods. The experimental uncertainties
have been calculated as described in the text.
The linear dependence of the structure factors
on D2O mol % demonstrates that the H2O/D2O
exchange is an isomorphous replacement. These
plots can be used to determine the signs of the
structure factors (Table 1), as previously de-
scribed (17,32).
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number of deuterons per lipid that can be easily detected. We
observed that the introduction of 0.54 deuterons per lipid led
to modest, but measurable changes in structure factors (data
not shown). We therefore hypothesized that at least ;0.5
deuterons per lipid are required to provide sufﬁcient contrast,
and we designed the experiments such that the concentration
of the deuterium exceeds this limit. We synthesized wild-
type and mutant FGFR3 TM domain variants with deuterated
F384 and L385, thus introducing 15 deuterons per peptide
(referred to as ‘‘D(FL) label’’). The incorporation of 4 mol %
of these peptides into POPC multilayers ensured the pres-
ence of 0.625 deuterons per lipid.
Overall, we synthesized four different peptides: TMwt,
TM
DðFLÞ
wt , TMmut, and TM
DðFLÞ
mut (see Fig. 1), following the
published synthesis protocol (37). The molecular weights of
the synthesized peptides, determined using MALDI-TOF
mass spectrometry, matched exactly the calculated ones.
Multilamellar POPC samples with 4 mol % of each peptide
were prepared as described in Materials and Methods. All
four peptides adopted transmembrane orientation in the
POPC multilayers characterized by low tilt (,20) with
respect to the bilayer normal. The tilt was measured using
oriented CD (OCD), as described in Materials and Methods
(see comparison of experimental and theoretical OCD spec-
tra in Fig. 2). The multilayer samples were placed in the neu-
tron beam and equilibrated at 76% RH (32). Diffraction
patterns were recorded at the Advanced Neutron Diffrac-
tometer/Reﬂectometer at the National Institute of Standards
and Technology Center for Neutron Research.
The major goal of the neutron diffraction experiments was
to measure the transbilayer distribution of the deuterium
label D(FL) in bilayers containing either the wild-type or the
mutant FGFR3 TM domain. To compare the neutron scatter-
ing length density proﬁles of different samples, the proﬁles
were scaled and placed on the so-called absolute-scale.
Absolute proﬁles have been discussed in detail previously
(17,31,32), and the scaling protocol is given in Materials and
Methods. The absolute structure factors for POPC bilayers
with 4 mol % TMwt, TM
DðFLÞ
wt , TMmut, and TM
DðFLÞ
mut , together
with the measured Bragg spacings, are shown in Table 1 for
100% H2O. The absolute structure factors, as a function of
D2O content, are plotted in Fig. 3. The calculated absolute
scattering length density proﬁles, obtained using Eq. 3, are
shown in Fig. 4 for 0%, 20%, and 50% D2O.
The direct comparison of the absolute wild-type proﬁles in
Fig. 5 reveals the position of the deuterated amino acids
within the bilayer thickness. Fig. 5 A compares the proﬁles of
POPC bilayers with 4 mol % TMwt (solid line) and 4 mol %
TM
DðFLÞ
wt (dashed line), hydrated in 100% H2O. The obvious
difference between the two wild-type proﬁles in the prox-
imity of the bilayer center is due to the exchange of 15 hy-
drogens with deuterons in amino acids F384 and L385. The
proﬁles overlap in the region away from the label, indicating
that the hydrogen/deuterium exchange in F384/L385 con-
stitutes an isomorphous replacement.
The experimental difference proﬁle for wild-type, obtained
by subtracting the POPC/TMwt proﬁle from the POPC/TM
DðFLÞ
wt
proﬁle, is shown in Fig. 5 B (also in Fig. 5 C) with the thick
dotted line.The differenceproﬁle is the transbilayer F384/L385
deuterium distributionD(FL), which can be deconvoluted into
two symmetric Gaussian distributions with centers 6ZD(FL)
and width AD(FL), as described in Materials and Methods. The
center of the ﬁtted Gaussian distribution gives the position,
6ZD(FL), of the D(FL) label. Note that the insertion of the
peptide is not unidirectional, but symmetric,which gives rise to
two symmetric label distributions around the bilayer center.
The quality of the ﬁt in Fig. 5 was judged by the value of
Rfit ¼ +hobsh¼1 jðF FfitÞðhÞj=+
hobs
h¼1 jFðhÞj, where F(h) indi-
cates the experimental structure factors and Fﬁt(h) indicates
the calculated structure factors for a particular Gaussian po-
sition and width pair, ZD(FL) and AD(FL) (35). A ﬁt was con-
sidered good if Rﬁt , Rself, where Rself describes the quality
of the experimental data (see Error Analysis in Materials and
Methods and Table 1). We found that, for wild-type, a range
of positions and widths (i.e., multiple ﬁts) are consistent
with the experimental data, as illustrated in Fig. 5, B and C.
For all these ﬁts, Rﬁt , Rself. In Fig. 5 B, ZD(FL) ¼ 0.2 A˚ and
AD(FL) ¼ 5.8 A˚, and in Fig. 5 C, ZD(FL) ¼ 2.4 A˚ and AD(FL) ¼
4.3 A˚. The individual F384/L385 Gaussians are shown with
dashed lines; their envelopes (solid line) approximate well
the experimental proﬁle (thick dotted line). The parameters
of the Gaussian distributions for wild-type, consistent with
the data (Rﬁt, Rself), are 0# ZD(FL)# 2.5 A˚ and 4# AD(FL)
# 5.8 A˚. Exact values of ZD(FL) and AD(FL) cannot be
TABLE 1 Observed absolute structure factors and their experimental uncertainties for POPC multilayers with 4 mol % peptide
h* TMwt TM
DðFLÞ
wt TMmut TM
DðFLÞ
mut TM
DðLVVÞ
mut
1 10.13 6 0.02 8.98 6 0.03 9.62 6 0.03 8.60 6 0.03 7.66 6 0.05
2 5.40 6 0.04 4.73 6 0.04 5.24 6 0.05 4.83 6 0.04 4.57 6 0.08
3 6.03 6 0.04 6.40 6 0.05 4.94 6 0.07 4.80 6 0.06 5.20 6 0.11
4 2.87 6 0.07 2.62 6 0.08 2.06 6 0.13 2.47 6 0.11 2.08 6 0.25
5 0.66 6 0.27 0.68 6 0.30 0.43 6 0.44 0.69 6 0.35 0.47 6 0.48
Rself
y 0.017 0.021 0.033 0.028 0.049
d (A˚)z 49.6 6 0.1 49.4 6 0.2 48.4 6 0.3 48.3 6 0.2 48.8 6 0.2
*Diffraction order.
ySelf R-factor, Rself ¼ +hobsh¼1 jsðhÞj=+
hobs
h¼1 jFðhÞj, describing the quality of the experimental data.zBragg spacing.
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calculated because the label is very close to the bilayer center
and the two Gaussians overlap.
The position of the D(FL) deuterium label at 0# ZD(FL)#
2.5 A˚ in wild-type suggests that the two labeled amino acids,
F384 and L385, are very close to the bilayer center. Therefore,
the hydropathy analysis prediction that V381 is in the middle
of the bilayer (Fig. 1), and thus the F384/L385 label is at
;5 A˚ from the bilayer center, is not consistent with the
experimental data.
Similarly towild-type, the position of theD(FL) label in the
R380 mutant can be determined by comparing the absolute
scattering density proﬁles of bilayers containing the mutant
peptides TMmut and TM
DðFLÞ
mut (Fig. 6), in the presence and
absence of the D(FL) label. Fig. 6 A compares the proﬁles of
bilayers with 4 mol % TMmut and TM
DðFLÞ
mut , hydrated in 100%
H2O. Just as in Fig. 5 A, the difference between the two
proﬁles is due to the isomorphous replacement of 15
hydrogens with deuterons in F384 and L385. Fig. 6 B shows
the experimental difference proﬁle for the mutant (thick
dotted line), obtained by subtracting the two proﬁles shown in
Fig. 6A. In this case, the exact position andwidth of the F384/
L385 deuterium distribution can be reliably determined as
ZD(FL) ¼ 4.6 6 0.2 A˚, AD(FL) ¼ 3.8 6 0.2 A˚; Rﬁt , Rself is
satisﬁed for these values only. Exact values can be obtained
because the label is not too close to the bilayer center and the
overlap of the two Gaussians is lower than in the wild-type
case. The individual F384/L385 Gaussians in Fig. 6 B are
shown with dashed lines; the solid line is their envelope.
The water distribution
Data collection for various H2O/D2O ratios serves several
purposes, provided that the H2O/D2O substitution is an
isomorphous replacement. First, it allows us to reduce the
random noise in the experimental data (17,32). Second, it
allows us to determine the phases of the structure factors, as
described in detail elsewhere (17,32). Third, it allows us to
directly determine the distribution of the water, uptaken by
the bilayer (31).
The H2O/D2O substitution is indeed an isomorphous
replacement for all samples that we examined, as evident
from the following observations: 1), the measured Bragg
spacings do not depend on the D2O mol fraction; 2), the
dependence of the structure factors on D2O content in Fig. 3
is linear; and 3), the proﬁles in Fig. 4, calculated for 0% D2O
(solid line), 20% D2O (dashed line), and 50% D2O (dotted
line), overlap completely outside the water region. Thus, the
proﬁles in Fig. 4 can be used to probe the hydration of the
bilayers with wild-type and mutant proteins. The difference
proﬁles in Fig. 7, obtained by subtracting the 0% D2O
proﬁles from the 20% D2O proﬁles, report the transbilayer
distribution of the water molecules, uptaken by bilayers
containing wild-type and mutant FGFR3 TM domains.
While the hydration of the lipid multilayers has been
determined as 6.2 waters per lipid at 76% RH (32), the
uptake of water by the bilayer changes in the presence of the
peptides (35). The scaling algorithm described in Materials
and Methods allows the determination of the unknown
hydration. By ﬁtting Gaussians to the experimental differ-
ence proﬁles, we determine the center and the width of the
water distribution, as well as the number of water molecules
per lipid (Eq. 7). The parameters of the water distributions
for bilayers containing wild-type and mutant TM domains
are presented in Table 3. The ﬁtted water Gaussians are
shown in Fig. 7 with the dashed lines. The solid lines in Fig.
7, which closely follow the experimental proﬁles (thick
FIGURE 4 Absolute neutron scattering length density
proﬁles of POPC bilayers with 4 mol % TMwt, TM
DðFLÞ
wt ,
TMmut, and TM
DðFLÞ
mut . Proﬁles are shown for 0% D2O (solid
lines), 20% D2O (dashed lines), and 50% D2O (dotted
lines). Proﬁles were generated using Eq. 3 and the ‘‘best’’
absolute structure factors (see Materials and Methods). The
differences between the proﬁles, due to the isomorphous
H2O/D2O replacement, report the overlapping water dis-
tributions of apposing bilayers (see also Fig. 7).
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dotted lines), are the envelopes of the two water Gaussians
from apposing bilayers.
Topology of the R380 mutant in POPC bilayers
As discussed above, the F384/L385 deuterium label distri-
bution in the mutant is centered at 4.6 A˚ from the bilayer
center (Fig. 6). The center of the membrane-embedded
segment, however, cannot be unambiguously determined
based solely on this result. For instance, if we assume that the
mutant TM domain is normal to the bilayer, which is con-
sistent with the OCD data in Fig. 2, two different topologies
would be consistent with a F384/L385 location at 4.6 A˚ from
the bilayer center. In the ﬁrst case, I387 and L388 are in the
middle of the bilayer, while in the second case, R380 is in the
middle of the bilayer.
To determine the exact topology of the mutant TM
domain, we synthesized a mutant variant TM
DðLVVÞ
mut with
deuterated L388, V389, and V390 (26 deuterons per peptide)
and we determined the position of the deuterium labelD(LVV)
within the bilayer thickness. The scaled absolute structure
factors are shown in Table 1. Fig. 8 A compares the absolute
scattering length density proﬁles of POPC bilayers with 4
mol % TMmut (solid line) and TM
DðLVVÞ
mut (dashed line). The
difference between the two proﬁles in Fig. 8 A is due to the
isomorphous replacement of 26 hydrogens with deuterons in
L388, V389, and V390. Fig. 8, B and C, show the difference
proﬁle (thick dotted line), which describes the transbilayer
distribution of the D(LVV) label. The label appears very close
to the bilayer center, and, just as in the case of wild-type,
multiple pairs of Gaussian distributions are consistent with the
FIGURE 5 (A) Absolute neutron scattering length density proﬁles for
bilayers with 4 mol % TMwt and TM
DðFLÞ
wt . The obvious difference between
the two proﬁles is due to the isomorphous replacement of 15 hydrogens in
F384 and L385 with 15 deuterons (see Fig. 1). (B,C) Difference proﬁles
showing the transbilayer distribution of the deuterated F384 and L385 in
wild-type. The experimental difference proﬁle (thick dotted line), with a
maximum at the bilayer center, is the envelope of two distributions centered
at ZD(FL) close to the bilayer center (dashed lines). Multiple pairs of Gaussian
parameters fposition (ZD(FL)), width (AD(FL))g (compare panels B and C)
produce ﬁts that are consistent with the data (Rﬁt , Rself), such that exact
values of ZD(FL) and AD(FL) cannot be calculated. In panels B and C, two
possible Gaussian distributions are shown with dashed lines; their envelopes
(solid line) approximate well the experimental proﬁle (thick dotted line). The
range of positions and widths that are consistent with the experimental data
are 0 # ZD(FL) # 2.5 A˚ and 4 # AD(FL) # 5.8 A˚.
FIGURE 6 (A) Absolute neutron scattering length density proﬁles for
bilayers with 4 mol % TMmut and TM
DðFLÞ
mut . (B) Difference proﬁles, showing
the transbilayer distribution of the deuterated F384 and L385 in the mutant.
For the mutant, the parameters of the F384/L385 deuterium distribution can
be determined with high experimental precision: ZD(FL) ¼ 4.6 6 0.2 A˚,
AD(FL) ¼ 3.86 0.2 A˚. The experimental difference proﬁle is shown with the
thick dotted line, the two F384/L385 Gaussians are shown with the dashed
lines, and their envelope is shown with the solid line.
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experimental data. In particular, distributions centered in the
range 1.4–2.8A˚ are all consistent with the data, i.e., Rﬁt, Rself.
Since three consecutive aminoacids, 388–390,weredeuterated,
the center of the distribution, at ;2 A˚ from the bilayer center,
points to the position of V389 within the bilayer thickness.
Thus, we ﬁnd that the D(FL) distribution for the mutant is
centered at 4.6 A˚ from the bilayer center, while the position
of D(LVV) and therefore, V389, is between 1.4 and 2.8 A˚.
These values could be used to gain information about the
disposition of the helix in the bilayer, if we assume that no
kinks exist in the hydrocarbon-core embedded segments.
Such an assumption could be justiﬁed, since hydrogen bonds
confer stability on TM helices (3), and kinks will likely per-
turb the hydrogen-bond network and destabilize the TM helices.
If the two labels,D(FL) andD(LVV), are positioned within
the same bilayer leaﬂet, the difference in their depth of
penetration would be only ;2–3 A˚. This would imply that
the TM domain is tilted with respect to the bilayer normal
(see Fig. 9 A). The tilt, expected to be between 60 and 74, is
inconsistent with the OCD data, shown in Fig. 2.
If the two deuterium labels, D(FL) and D(LVV), are on the
opposite sides of the midbilayer plane, the distance between
them would be between 6 and 7.4 A˚. On the other hand,
assuming that the rise per residue in the helix is 1.5 A˚, the
distance between the two labels along the helix axis can be
calculated as 6.75 A˚. Therefore, the helix tilt in this case
would be between 0 and 27 (Fig. 9 B), in agreement with the
OCD data.
The above reasoning leads us to conclude that the two labels,
D(FL) andD(LVV), are on opposite sides of the bilayer center.
The position of theD(FL) label is known exactly, at 4.6 A˚ from
the bilayer center. The helix tilt, as determined by OCD, is
between 0 and 20with respect to the bilayer normal. Although
the exact tilt angle is unknown, the depth of penetration of
various amino acids in the hydrocarbon core can be determined
FIGURE 7 Experimental (thick dotted lines) and ﬁtted difference proﬁles
describing the water distribution in bilayers with wild-type and mutant
FGFR3 TM domains. The ﬁtted water Gaussians, derived from the averaged
parameters shown in Table 3, are shown with the dashed lines. The solid
lines are the envelopes of the two water Gaussians from apposing bilayers.
FIGURE 8 (A) Absolute neutron scattering length density proﬁles for
bilayers with 4 mol % TMmut and TM
DðLVVÞ
mut at 76% RH. The difference
between the two proﬁles is due to the isomorphous replacement of 26
hydrogens in L388, V389, and V390 with 26 deuterons (see Fig. 1). (B,C)
Difference proﬁles showing the transbilayer distribution of the deuterated
L388, V389, and V390 in the mutant. Multiple pairs of Gaussian parameters
fposition (ZD(LVV)), width (AD(LVV))g produce ﬁts that are consistent with
the data (Rﬁt, Rself). The individual deuterium label distributions are shown
with dashed lines; their envelopes (solid line) approximate well the
experimental proﬁle (thick dotted line). The range of positions and widths
that are consistent with the experimental data are 1.4# ZD(LVV)# 2.8 A˚ and
6.3 # AD(LVV) # 7.8 A˚.
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(Fig. 10). The midpoint of the mutant TM FGFR3 domain is
between I387 and L388, andR380 is at;11 A˚ from the bilayer
center (Fig. 10). Therefore, the experimental data do not
support the hydropathy analysis prediction that V381 in the
mutant is located in the middle of the bilayer.
DISCUSSION
Neutron diffraction studies of depth of penetration
of amino acids in ﬂuid bilayers
Neutron diffraction experiments, combined with speciﬁc
deuteration of amino acids, offer a means to determine the
depth of penetration of the deuterated amino acids within the
bilayer thickness. Here we have veriﬁed this approach by
demonstrating that the hydrogen-deuterium substitution in a
TM domain is indeed an isomorphous replacement that
introduces no perturbations in the bilayer structure, as evi-
dent from the complete overlap of proﬁles away from the
labels in Figs. 5 A, 6 A, and 8 A.
A crucial issue for the feasibility of neutron diffraction
experiments that locate amino acids within the bilayer thick-
ness is the detection limit for deuterium (i.e., the number of
deuterons per lipid that can be detected), as determined by
the number of deuterons per peptide and the peptide/lipid
ratio. In the present experimental study, we introduced at
least 0.625 deuterons per lipid, and we showed that these
0.625 deuterons provide sufﬁcient contrast, such that the
position of the deuterons within the bilayer can be resolved.
This conclusion is supported by comparing values of Rself,
measuring the quality of the data, and Rdiff, reporting the
difference in structure factors due to the presence of the
deuterium label. As shown in Tables 2 and 3, the values of
Rdiff in our experiments exceed the values of Rself two-to-
threefold, such that the contrast introduced by the speciﬁc
FIGURE 9 (A) If the two deuterium labels, D(FL) and D(LVV), are
positioned within the same bilayer leaﬂet, the difference in their depth of
penetration would be only ;2–3 A˚. Therefore, the FGFR3 TM helix would
be tilted. The tilt, expected to be between 60 and 74, is inconsistent with the
OCD data, shown in Fig. 2. (B) If the two deuterium labels, D(FL) and
D(LVV), are on the opposite sides of the midbilayer plane, the tilt is ,27,
consistent with the OCD data.
FIGURE 10 Sketch of the hydrocarbon core-embedded segment of the
G380R mutant, which is consistent with the neutron diffraction and OCD
data. The tilt of the helix, based on the OCD data, is between 0 and 20 with
respect to the bilayer normal. The position of the F384/L385 label is at 4.6 A˚
from the bilayer center, and V389 is positioned within the opposite bilayer
leaﬂet. (A) Tilt angle ¼ 0. R380 (underlined) is located at ;11 A˚ from the
bilayer center, while R397 is at ;14 A˚ from the bilayer center. This
structural picture is consistent with work by Hessa et al. (4), who showed
that arginine is well tolerated at the periphery of the hydrocarbon core
region, but not in the center of the bilayer. (B) Tilt angle ¼ 20. R380
(underlined) is located at ;11 A˚ from the bilayer center, while R397 is at
;13 A˚ from the bilayer center. Although the exact tilt of the helix is not
known, the depth of penetration of the amino acids in the hydrocarbon core
can be determined, assuming that there are no kinks in the helix.
TABLE 2 Gaussian parameters for the D(FL) and D(LVV)
deuterium distributions in POPC bilayers containing 4 mol %
wild-type or mutant TM domains
Wild-type D(FL) Mutant D(FL) Mutant D(LVV)
ZD (A˚)* 0 # ZD #2.5 4.6 6 0.2 1.4 # ZD #2.8
AD (A˚)
y 4.0 # AD #5.8 3.8 6 0.3 6.3 # AD #7.5
Rdiff
z 0.099 0.099 0.123
Rﬁt
§ 0.011–0.013 0.016 0.021–0.023
*Center of the deuterium distribution.
yWidth of the deuterium distribution.
zDifference R-factor, Rdiff ¼ +hobsh¼1 jðFðhÞ  FDðhÞÞj=+hobsh¼1 jFðhÞj, where
F(h) and FD(h) are the structure factors in the absence and presence of the
peptide deuterium label, either D(FL) or D(LVV); see text. The transbilayer
distribution of the deuterium label can be determined only if Rdiff . Rself.
§R-factor for the ﬁt, Rfit ¼ +hobsh¼1 jðF FfitÞðhÞj=+hobsh¼1 jFðhÞj.
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deuteration is not ‘‘hidden’’ within the experimental noise.
Comparison between values of Rdiff and Rself should be
always carried out in similar experiments. If Rdiff# Rself, the
differences in structure factors due to the label will be similar
to the experimental noise, and the position of the deuterium
label cannot be determined. Given the values of Rself and Rdiff
in our experiments, it appears that the detection of ,;0.6
deuterons per lipid is problematic. However, as long as there
are .0.6 deuterons per lipid, neutron diffraction provides a
direct means to determine the depth of penetration of amino
acids in bilayers.
The achondroplasia mutation does not induce a
major change in membrane topology
Oriented CD experiments show that the wild-type and the
mutant adopt transmembrane orientations, characterized by
low tilt (,20) with respect to the bilayer normal. Thus,
Arg380 inserts into the bilayer, and does not cause a major
change in bilayer topology.
Previous work has shown that the two peptides have
similar dimerization propensities in lipid bilayers (22), and
therefore similar distributions of monomers and dimers at
each peptide concentration. Based on measured dimerization
equilibrium constants (22), both peptides are expected to be
predominantly in the dimeric state at the concentration used
in the neutron diffraction experiments (;70% in the dimeric
state). Molecular modeling of the wild-type dimer (20)
predicts a crossing angle between helices of ;17, sug-
gesting that the helix tilt in the dimeric state is 8.5 with
respect to the bilayer normal. This prediction is within the
experimentally determined tilts of 20 or less for both wild-
type and mutant. We note that the tilt of the monomeric and
dimeric peptides may differ, and the experiments may report
the average value. Furthermore, we note that variations in tilt
between 0 and 20 cannot be detected by either OCD or
diffraction, as illustrated in Figs. 2 and 10.
Structural consequences of the
achondroplasia mutation
The results obtained in this article allow us to compare
directly the structural parameters of bilayers with 4 mol %
wild-type FGFR3 TM domain and the achondroplasia-
causing R380 mutant. The ﬁrst obvious difference between
bilayers with wild-type and mutant TM domains is their
Bragg spacings. The Bragg spacing reports the thickness of
the unit cell, and thus the thickness of the bilayer containing
the peptides plus the associated water. The Bragg spacing is
;49.5 A˚ in the presence of wild-type and ;48.5 A˚ in the
presence of the mutant. The decrease of ;1 A˚ is small, yet
signiﬁcant.
The measured structure factors in Table 1 are on the
absolute scale, such that they can be directly compared. We
see slight, but signiﬁcant differences between structure
factors of bilayers with wild-type and mutant TM domains.
Furthermore, the depth of penetration of the deuterium F384/
L385 label into the bilayer is also different for the wild-type
and the mutant. The position of the label is between 0 and
2.5 A˚ for wild-type and 4.6 A˚ for the mutant. While G380
in wild-type is positioned at ;6 A˚ from the bilayer center,
the mutant R380 is at ;11 A˚ from the bilayer center. Thus,
it appears that the achondroplasia mutation induces a
shift in the membrane-embedded segment of FGFR3. The
shift, induced by R380, brings R397 inside the hydrocarbon
core, at;13–14 A˚ from the bilayer center (see Fig. 10). This
structural picture is consistent with work by Hessa et al. (4),
who showed that arginine is well tolerated at the periphery
of the hydrocarbon core region, but not in the center of
the bilayer. It should be further noted that hydropathy anal-
ysis tools do not predict correctly the location of R380,
and the overall topology of FGFR3 TM domain in the
bilayer.
Unlike the other structural parameters, the transbilayer
distribution of the water, uptaken by bilayers with wild-type
and mutant proteins, appears very similar. Thus, the R380
mutation does not affect the water uptake by the bilayer.
Mechanism of pathogenesis in achondroplasia
The G380R mutation in FGFR3 TM domain causes achon-
droplasia, an autosomal dominant disorder that affects the
maturation of the cartilage growth plate of long bones (24).
The underlying cellular basis of the disorder is a defect in
chondrocyte function during endochondral bone formation.
TABLE 3 Gaussian parameters for the water distributions
TMwt TM
DðFLÞ
wt WTaverage
{ TMmut TM
DðFLÞ
mut MUTaverage
k
Zw (A˚)* 22.4 6 0.1 22.2 6 0.1 22.3 6 0.1 22.1 6 0.1 21.6 6 0.1 21.8 6 0.1
Aw (A˚)
y 6.1 6 0.1 6.2 6 0.1 6.2 6 0.1 6.5 6 0.2 6.4 6 0.2 6.5 6 0.1
Nw
z 8.0 6 0.3 6.9 6 0.1 7.5 6 0.7 7.6 6 0.3 7.6 6 0.4 7.6 6 0.3
Rﬁt
§ 0.0056 0.0133 0.0061 0.0069
*Center of water distribution.
yWidth of water distribution.
zNumber of water molecules per lipid.
§R-factor for the water ﬁt, Rfit ¼ +hobsh¼1 jðF FfitÞðhÞj=+
hobs
h¼1 jFðhÞj. For a good ﬁt, Rﬁt , Rself (Rself deﬁned in Table 1).
{Averaged values for TMwt and TM
DðFLÞ
wt .
kAveraged values for TMmut and TM
DðFLÞ
mut .
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The molecular mechanism of pathology induction is under
debate, and two different mechanisms have been proposed to
contribute to pathogenesis: 1), R380-mediated FGFR3 dimer
stabilization (19); and 2), slow downregulation of the
activated mutant receptors (29,30). We have previously
reported that the mutation does not alter the stability of the
FGFR3 TM domain dimer (22), and thus the phenotypic
changes cannot be described simply by enhanced dimer
stability.
Monsonego-Ornan and colleagues (29) have shown that
the activated G380R receptors accumulate in the plasma
membrane because they are downregulated very slowly. Cho
et al. (28) have demonstrated that the mutant receptors
escape lysosomal degradation and are recycled back to the
plasma membrane, thus prolonging signaling. Our previous
ﬁnding that the mutation does not stabilize the FGFR3 TM
dimer (22) emphasizes the importance of the observed slow
downregulation of the mutant receptor in achondroplasia.
The exact mechanism of the slow downregulation, however,
is unknown. Here we observe structural changes as a
consequence of the R380 mutation: in a model system, the
mutation induces a decrease in Bragg spacing and a shift in
the membrane-embedded segment. It is possible that the
observed structural changes play a role in pathogenesis in
achondroplasia. For instance, the basis of the compromised
downregulation of the mutant receptor could be structural.
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